Company: IOBT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001193125-25-180860
Chunk: 0

Company: IO Biotech, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 0
---
IO BIOTECH, INC. 

Consolidated Balance Sheets 

(In thousands, except share and per share amounts) 

(unaudited) 

     June 30,2025

     December 31,2024

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     28,131

     $
     60,031

     Prepaid expenses and other current assets

     10,849

     4,920

     Total current assets

     38,980

     64,951

     Restricted cash

     268

     268

     Property and equipment, net

     603

     638

     Right of use lease asset

     1,470

     1,725

     Other non-current assets

     1,005

     117

     Total non-current assets

     3,346

     2,748

     Total assets
      
     $
     42,326

     $
     67,699

     Liabilities and stockholders’ equity

     Current liabilities

     Accounts payable
      
     $
     5,537

     $
     4,661

     Lease liability - current

     768

     717

     Accrued expenses and other current liabilities

     13,592

     14,108

     Total current liabilities

     19,897

     19,486

     Lease liability - non-current

     868

     1,198

     Term loan debt, net

     6,720

     —

     Common stock warrants

     13,249

     —

                    Total non-current liabilities

     20,837

     1,198

     Total liabilities

     40,734

     20,684

     Commitments and contingencies (Note 10)

     Stockholders’ equity

     Preferred stock, par value of $0.001 per share; 5,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024

     —

     —

     Common stock, par value of $0.001 per share; 300,000,000 shares authorized at June 30, 2025 and December 31, 2024; 65,880,914 shares issued and outstanding as of